open access

Vol 17, No 1 (2011)
Review papers
Published online: 2011-04-22
Get Citation

Vascular complications in essential thrombocythaemia

Małgorzata Gacka, Rajmund Adamiec
Acta Angiologica 2011;17(1):37-48.

open access

Vol 17, No 1 (2011)
Review papers
Published online: 2011-04-22

Abstract

Essential thrombocythaemia is a myeloproliferative disorder characterised by both thrombotic and haemorrhagic events. Proper diagnosis enables administration of adequate therapeutic regimens, which can prevent occurrence of further thrombotic episodes. Treatment mainly involves cytoreductive and antiplatelet drugs administered in high-risk patients. New therapeutic agents modulating JAK2 kinase activity can possibly be used in the future.
Acta Angiol 2011; 17, 1: 37–48

Abstract

Essential thrombocythaemia is a myeloproliferative disorder characterised by both thrombotic and haemorrhagic events. Proper diagnosis enables administration of adequate therapeutic regimens, which can prevent occurrence of further thrombotic episodes. Treatment mainly involves cytoreductive and antiplatelet drugs administered in high-risk patients. New therapeutic agents modulating JAK2 kinase activity can possibly be used in the future.
Acta Angiol 2011; 17, 1: 37–48
Get Citation

Keywords

essential thrombocythaemia; vascular complications; arterial thrombosis; venous thrombosis; JAK2 V617F mutation

About this article
Title

Vascular complications in essential thrombocythaemia

Journal

Acta Angiologica

Issue

Vol 17, No 1 (2011)

Pages

37-48

Published online

2011-04-22

Bibliographic record

Acta Angiologica 2011;17(1):37-48.

Keywords

essential thrombocythaemia
vascular complications
arterial thrombosis
venous thrombosis
JAK2 V617F mutation

Authors

Małgorzata Gacka
Rajmund Adamiec

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl